The Current Evidence in Support of Multimodal Treatment of Locally Advanced, Potentially Resectable Esophageal Cancer | Zendy

Johannes Zacherl | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Current Evidence in Support of Multimodal Treatment of Locally Advanced, Potentially Resectable Esophageal Cancer

Author(s) -

Johannes Zacherl

Publication year - 2014

Publication title -

digestive diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.879

H-Index - 66

eISSN - 1421-9875

pISSN - 0257-2753

DOI - 10.1159/000357189

Subject(s) - medicine , esophageal cancer , perioperative , chemotherapy , esophagectomy , neoadjuvant therapy , cancer , oncology , randomized controlled trial , adenocarcinoma , radiation therapy , surgery , breast cancer

Treatment of locally advanced resectable esophageal cancer is challenging. In the past three decades surgical treatment has become safer, chemotherapy more powerful and radiation techniques more precise. Today's stage-dependent treatment relies on modern diagnostic tools such as multidetector helical CT, high-frequency endoscopic ultrasound, PET, image fusion techniques and MRI. Specialists cooperate on multidisciplinary tumor boards that follow transparent decision trees based on the newest evidence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research